Effects of the long-acting monoamine reuptake inhibitor indatraline on cocaine self-administration in rhesus monkeys

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 1, 1999, Pages 60-69

  Negus, S Stevens ^a,b   Brandt, Michael R ^a   Mello, Nancy K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; INDATRALINE; LONG ACTING DRUG; MONOAMINE OXIDASE INHIBITOR;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT DISORDER; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG SELF ADMINISTRATION; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; BODY WEIGHT; COCAINE; COCAINE-RELATED DISORDERS; DISCRIMINATION LEARNING; DOPAMINE UPTAKE INHIBITORS; INDANS; MACACA MULATTA; PSYCHOMOTOR PERFORMANCE; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 0032872015     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Amt J, Christensen AV and Hyttel J (1985) Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain. Naunyn-Schmiedekerg's Arch Pharmacol 329:101-107.
2. Ball JC and Rosa A (eds) (1991) The Effectiveness of Methadone Maintenance Treatment. Springer-Verlag, New York.
3. Balster RL and Schuster CR (1973) Fixed-interval schedule of cocaine reinforcement: Effect of dose and infusion duration. J Exp Anal Behav 20:119-129.
4. Bergman J, Kamien JB and Spealman RD (1990) Antagonism of cocaine self-administration by selective dopamine D1 and D2 antagonists. Behav Pharmacol 1:355-363.
5. Birmingham AM, Nader SH, Grant KA, Davies HM and Nader MA (1998) Further evaluation of the reinforcing effects of the novel cocaine analog 2β-propanoyl-3β-(4-tolyl)-tropane (PTT) in rhesus monkeys. Psychopharmacology 136:139-147.
6. Bogeso KP, Christensen AV, Hyttel J and Liljefors T (1985) 3 Phenyl-1-indanamines: Potential antidepressant activity and potent inhibition of dopamine, norepinephrine and serotonin uptake. J Med Chem 28:1817-1828.
7. Burkett G, Yasin SY, Palow D, LaVoie L and Martinez M (1994) Patterns of cocaine hinging: Effect on pregnancy. Am J Obstet Gynecol 171:372-378.
8. Caine SB and Koob GF (1995) Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav Pharmacol 6:333-347.
9. Callahan PM and Cunningham KA (1995) Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors. J Pharmacol Exp Ther 274:1414-1424.
10. Cunningham KA and Callahan PM (1991) Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology 104:177-180.
11. Dworkin SI, Lambert P, Sizemore GM, Carroll FI and Kuhar MJ (1998) RTI-113 Administration reduces cocaine self-administration at high occupancy of dopamine transporter. Synapse 30:49-55.
12. Farfel GM, Kleven MS, Woolverton WL, Seiden LS and Perry BD (1992) Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey. Brain Res 578:235-243.
13. Glowa JR, Wojnicki FHE, Matecka D, Bacher JD, Mansbach RS, Balster RL and Rice KC (1995a) Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: I. Dependence on unit dose of cocaine. Exp Clin Psychopharm 3:219-231.
14. Glowa JR, Wojnicki FHE, Matecka D, Rice KC and Rothman RB (1995b) Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: II. Comparisons with other drugs and repeated administrations. Exp Clin Psychopharm 3:232-239.
15. Hyttel J (1982) Citalopram - Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuro-Psychopharmacol Biol Psychiatry 6:277-295.
16. Hyttel J and Larsen JJ (1985) Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline and serotonin. J Neurochem 44:1615-1622.
17. Kleven MS, Anthony AW and Woolverton WL (1990) Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 254:312-317.
18. Kleven MS and Koek W (1998) Discriminative stimulus properties of cocaine: Enhancement by monoamine reuptake blockers. J Pharmacol Exp Ther 284:1015-1025.
19. Kleven MS and Woolverton WL (1990) Effects of continuous infusions of SCH 23390 on cocaine- or food-maintained behavior in rhesus monkeys. Behav Pharmacol. 1:365-373.
20. Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199:649-661.
21. Koob GF and Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science (Wash DC) 242:715-723.
22. Lamas X, Negus SS, Hall E and Mello NK (1995) Relationship between the discriminative stimulus effects and plasma concentrations of intramuscular cocaine in rhesus monkeys. Psychopharmacology 121:331-338.
23. 3H] cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther 251:131-141.
24. Mansbach RS and Balster RL (1993) Effects of mazindol on behavior maintained or occasioned by cocaine. Drug Alcohol Depend 31:183-191.
25. Mello NK, Lukas SE, Bree MP and Mendelson JH (1990) Desipramine effects on cocaine self-administration by rhesus monkeys. Drug Alcohol Depend 26:103-116.
26. Mello NK and Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsyckopharmacology 14:375-424.
27. Mendelson JH and Mello NK (1996) Drug therapy: Management of cocaine abuse and dependence. N Eng J Med 334:965-972.
28. Nader MA, Grant KA, Davies HM, Mach RH and Childers SR (1997) The reinforcing and discriminative stimulus effects of the novel cocaine analog 2β-propanoyl-3β-(4-tolyl)-tropane in rhesus monkeys. J Pharmacol Exp Ther 280:541-550.
29. Negus SS, Mello NK, Lamas X and Mendelson JH (1996) Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 278:879-890.
30. Negus SS, Mello NK, Portoghese PS and Lin C-E (1997) Effects of kappa opioids on cocaine self-administration by rhesus monkeys. JPharmacol Exp Ther 282:44-55.
31. Negus SS, Mello NK, Portoghese PS, Lukas SE and Mendelson JH (1995) Role of delta opioid receptors in the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 273:1245-1256.
32. Pettier R and Schenk S (1993) Effects of serotonergic manipulations on cocaine self-administration in rats. Psychopharmacology 110:390-394.
33. Rosenzweig-Lipson S, Bergman J, Spealman RD and Madras BK (1992) Stereoselective behavioral effects of Lu 19-005 in monkeys: Relation to binding at cocaine recognition sites. Psychopharmacology 107:186-194.
34. Spealman RD (1993) Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys. Psychopharmacology 112:93-99.
35. Spealman RD (1995) Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 275:53-62.
36. Terry P, Witkin JM and Katz JL (1994) Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. J Pharmacol Exp Ther 270:1041-1048.
37. Winer BJ (1971) Statistical Principles in Experimental Design. McGraw Hill Book Co., New York.
38. Wojnicki FHE, Rothman RB, Rice KC and Glowa JR (1999) Effects of phentermine on responding maintained under multiple fixed-ratio schedules of food and cocaine presentation in the rhesus monkey. J Pharmacol Exp Ther 288:550-560.